SMO Clinplus Co (SZSE:301257) Net Change in Cash : ¥-128.3 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is SMO Clinplus Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

SMO Clinplus Co's Net Change in Cash for the three months ended in Mar. 2024 was ¥71.0 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-128.3 Mil.

SMO Clinplus Co Net Change in Cash Historical Data

The historical data trend for SMO Clinplus Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SMO Clinplus Co Net Change in Cash Chart

SMO Clinplus Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

32.63

13.47

32.62

541.79

-184.11

SMO Clinplus Co Quarterly Data
	Dec17	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Change in Cash	Get a 7-Day Free Trial															15.16	-60.30	-267.25	128.28	70.97

SMO Clinplus Co Net Change in Cash Calculation

SMO Clinplus Co's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	114.847	+	-284.451	+	-14.507	+	0
	=	-184.1

SMO Clinplus Co's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -8.551 + 81.122 + -1.598 + 0

= 71.0

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-128.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SMO Clinplus Co Net Change in Cash Related Terms
Thank you for viewing the detailed overview of SMO Clinplus Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

SMO Clinplus Co (SZSE:301257) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SMO Clinplus Co Ltd (SZSE:301257) » Definitions » Net Change in Cash

Comparable Companies

SHSE:688468 SZSE:300439 SHSE:603122 SZSE:301060 SZSE:300639 SHSE:603716 SHSE:688193 SZSE:300396 SZSE:300685 SZSE:300463 TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH

Traded in Other Exchanges

N/A

Address

No. 105 Sinan Road, Room 108, Building 1, Huangpu District, Shanghai, CHN, 200001

Website

http://www.smo-clinplus.com

SMO Clinplus Co Ltd is engaged in providing SMO services to domestic and foreign pharmaceutical companies, medical device companies and clinical research and development of some health-related products. The services provided include Preliminary model establishment, Preliminary plan preparation, Initiation of clinical trial sites, On-site implementation, and Comprehensive project management.

Executives

Lai Chun Bao Director

Ma Lin Director

SMO Clinplus Co (SZSE:301257) Headlines

No Headlines